Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Juan Diego Mendoza-Saldaña"'
Publikováno v:
Gaceta Sanitaria, Vol 35, Iss 6, Pp 598-599 (2021)
Externí odkaz:
https://doaj.org/article/802c948184bf411f9b37c72baf1bdf25
Autor:
Fiorella Pando-Alvarez, Juan Diego Mendoza-Saldaña, Astrid Altamirano-Quiroz, Jorge Pilco-Inga, Gustavo Saldivar-Ampuero, Juan-Carlos Samamé-Perez-Vargas, Bruno Pedraz-Petrozzi
Publikováno v:
Revista de Neuro-Psiquiatria. 83:5-14
Objetivo: Describir los diferentes elementos psico-espirituales en pacientes con cáncer aplicando la escala Functional Assessment of Chronic Illness Therapy - Spiritual Well Being, FACIT-Sp (Evaluación Funcional de Terapia de Enfermedades Crónicas
Autor:
Juan-Diego Mendoza-Saldaña, José Enrique Viton-Rubio, Susana Brissvany Guzman-Carrasco, Niels Victor Pacheco-Barrios, Carla Rebeca Lainez-Casal
Publikováno v:
Archives of environmentaloccupational health. 77(9)
The healthcare workforce has played an integral role in fighting COVID-19 and continues to do so despite the continuous adverse outcomes. To address this issue, official public data concerning COVID-19 cases and deaths of Peruvian physicians was used
Publikováno v:
Asian Journal of Psychiatry
Peru reported its first case of Coronavirus disease 2019 (COVID-19) on March 6, 2020 (Worldometer, 2020) and it has become the sixth most infected nation, with 814.829 cases and the second country with the highest mortality rate (98.1 deaths per 100.
Publikováno v:
Gaceta Sanitaria
Gaceta Sanitaria, Vol 35, Iss 6, Pp 598-599 (2021)
Gaceta Sanitaria v.35 n.6 2021
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Gaceta Sanitaria, Vol 35, Iss 6, Pp 598-599 (2021)
Gaceta Sanitaria v.35 n.6 2021
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
On August 2020, National Institute of Statistics and Information updated population data (32,625,948 citizens)1 in which Peru became the second country with the highest mortality rate from coronavirus disease 2019 (COVID-19) around the world with 91.
Autor:
Lidia M. López, Grisel Jesús Ynga-Meléndez, Juan Diego Mendoza-Saldaña, Juan Alonso Leon-Abarca, Juan Carlos Madrid-Cisneros, Roberto A. Accinelli
Publikováno v:
Travel Medicine and Infectious Disease
Background Currently, there is no formally accepted pharmacological treatment for COVID-19. Materials and methods We included COVID-19 outpatients of a Peruvian primary care center from Lima, Peru, who were treated between April 30 - September 30, 20